The growth of Rickettsia prowazekii Madrid E was monitored in mouse L929 cells subcultured for several weeks in the presence of gamma interferon (IFN--y) to determine whether the rickettsiae would be eliminated from or would persist in these cultures. R. prowazekii exhibited two distinct patterns in these IFN-y-treated cultures. In some cases, IFN-'y-induced inhibition of rickettsial growth led to elimination of the rickettsiae from the L929 cell cultures; in other cases, the initial inhibition of rickettsial growth was followed by establishment of a persistent rickettsial infection in the IFN--y-treated L929 cells. During the first 3 days after infection, the growth rate of the L929 cells was significantly lower and higher percentages of the cells were killed in the IFN-y-treated, R. prowazekii-infected cultures than in the untreated, R. prowazekii-infected cultures or the mock-infected cultures, whether treated or untreated. This suppression of cell growth occurred in the infected, IFN-y-treated cultures that eventually exhibited the elimination pattern as well as the IFN--y-treated cultures that became persistently infected. It was not possible to predict the outcome of a particular infection from the early growth pattern of the culture. It was determined that the L929 cells in the persistently infected, IFN--y-treated cultures had not lost the ability to respond to IFN--y. These cells, after treatment with an antibiotic to eliminate the persistent rickettsiae, retained the ability to inhibit both the replication of vesicular stomatitis virus and the growth of R. prowazekii Madrid E after treatment with IFN--y. In contrast, rickettsiae isolated from two persistently infected, IFN--y-treated cultures were less sensitive than R. prowazekii Madrid E to the antirickettsial effects of IFN--y in standard L929 cells. The maintenance of the phenotype of these altered rickettsiae during plaque purification and passage in the absence of IFN-y suggests an alteration at the genetic level rather than phenotypic adaptation.
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Rickettsia prowiazekii is an obligate intracellular bacterium that grows in the cytoplasm of its host cells, unbounded by a phagosomal or phagolysosomal membrane (19) . The etiological agent of epidemic typhus in humans, R. proi'azekii proliferates in the endothelial cells that line the small blood vessels (27) . This organism can also grow in macrophages (6) .
The growth of R. proit'azekii in cultured fibroblasts and macrophagelike cells is inhibited by gamma interferon (IFNy) (13, 16, 17, 25, 26) , and this lymphokine has been shown to be important in host defense against Rick-ettsiai conorii infection in mice (11) . However, the mechanisms of action of IFN-y against rickettsiae in vitro and in vivo have not been defined.
In previous studies with fibroblasts (mouse L929 cells and human fibroblasts), the growth of R. prowtazekii was monitored in IFN-y-treated cells during a 2-day period (13, 17) . Rickettsial growth was dramatically inhibited in these experiments, but rickettsiae were still detectable by staining after 2 days. It is not known if IFN-y can cure cultured fibroblasts of infection with R. prow'azekii.
In the present study, the growth of R. prowazekii Madrid E was monitored in L929 cells subcultured for several weeks in the presence of IFN-y to determine whether the rickettsiae would be eliminated from or would persist in these cultures. In addition, the growth and viability of the L929 cells after infection with R. prowiazekii Madrid E and treatment with IFN-y were examined. We report that R. pr-ow azekii Madrid E exhibited two distinct patterns in cultures of L929 cells treated with IFN-y for several weeks.
* Corresponding author.
In some cases, IFN-y-induced inhibition of rickettsial growth led to elimination of the rickettsiae from the L929 cell cultures; in other cases, the initial inhibition of rickettsial growth was followed by establishment of a persistent rickettsial infection in the IFN-y-treated L929 cells. Rickettsiae isolated from these persistently infected, IFN-y-treated cultures had reduced sensitivity to the antirickettsial effect of IFN--y.
MATERIALS AND METHODS
Cell cultures. Mouse L929 cells were purchased from Flow Laboratories, Inc. (McLean, Va.) and grown in Eagle minimal essential medium supplemented with 10% newborn bovine serum. Mouse 3T3-A31 cells were purchased from the American Type Culture Collection, Rockville, Md., and grown in Dulbecco modified Eagle medium supplemented with 10% newborn bovine serum. Cultures of human foreskin fibroblasts were kind gifts from Frank Pindak, University of South Alabama, and were grown in Eagle minimal essential medium supplemented with 10%. fetal bovine serum. All cells were grown as monolayers in a humidified atmosphere of 3% CO, in air at 34°C. The bovine sera were heated at 56°C for 30 min before use.
Rickettsiae. Six-day-old embryonated, antibiotic-free hen eggs (Truslow Farms, Chestertown, Md.) were inoculated with a seed pool of R. prowazekii Madrid E (yolk sac passage 280). Eight days later, the rickettsiae were harvested and purified from the infected yolk sacs as described previously (15) . Viable rickettsiae were enumerated by the antibody hemolysis method of Walker and Winkler (18) .
IFN-y. Recombinant murine IFN-y derived from Ec herichia coli was generously provided by Genentech, Inc.
(South San Francisco, Calif.). IFN--y was assayed by a cytopathic effect inhibition assay with vesicular stomatitis virus and L929 cells. The assay was modified from that of Havell and Vilcek (8) as previously described (14) . IFN-y activity was calibrated against a reference preparation of murine IFN-y (GaO2-901-533; National Institute of Allergy and Infectious Diseases, Bethesda, Md.). One unit of IFN-y in the present study is equivalent to 1.28 U of IFN-y in our previous work (13, 17) .
Infection of L929 cells with rickettsiae, assessment of L929 cell growth and viability, and measurement of rickettsial growth. L929 cells were harvested from monolayer cultures by incubation with 0.5% trypsin and 0.02% disodium EDTA in a salt solution (Flow Laboratories, Inc.). After being washed, the cells were suspended in serum-supplemented medium (MS) at a concentration of 2 x 106 viable (trypan blue-excluding) cells per ml. Rickettsiae were diluted in Hanks balanced salt solution supplemented with 5 mM L-glutamic acid (monopotassium salt) and 0.1% gelatin (HBSSGG), and an equal volume of rickettsiae (approximately 2 x 108/ml) was added to each cell suspension. For mock infection, HBSSGG alone was added to the cells. After incubation in a shaking water bath at 34°C for 1 h, the cells were washed and planted into culture plates (diameter of 60 or 100 mm) that contained MS alone or MS plus IFN-y (final concentration, 12 U/ml). Previous studies with both X-irradiated and nonirradiated L929 cells indicated that IFN--y at this concentration markedly inhibits the growth of R. prowazekii in these cells (13, 17) . For determination of the initial rickettsial infection, samples of the washed cell suspensions were immediately centrifuged onto microscope slides, dried, fixed, and stained as previously described (14, 15 later, the yolk sacs were removed aseptically from the viable embryos, and the rickettsiae were harvested. Rickettsial suspensions prepared from infected yolk sacs were diluted and the rickettsiae were plaqued on 3T3-A31 cells or human foreskin fibroblasts by a method modified from that of Hanson (7). After two cycles of plaque purification, suspensions of the plaque-purified rickettsiae (R.
prowazekii 427-19 and R. prorowaZekii were prepared from infected L929 cell cultures. In addition, the rickettsial isolates were inoculated into embryonated hen eggs, and rickettsial suspensions were prepared from the infected yolk sacs approximately1 week later.
Statistics. Data were analyzed by two-tailed Student's t test. (i) Growth of R. prowazekii. Initially, the percentage of cells infected with rickettsiae was 84% + 10% and the average number of rickettsiae per infected cell was 6.5 ± 2.2 (mean ± standard deviation). As expected, in the infected cultures that were not treated with IFN-y, the rickettsiae grew well during the first 3 days: the percentage of cells infected increased to 96%±+ 8% and the average number of rickettsiae per infected cell increased to 64 ± 15. These controls demonstrated that the rickettsial inocula were viable and capable of growth in these cultures. In contrast, during this period in the IFN-y-treated cultures, the percentage of cells infected decreased, and the average number of rickettsiae per infected cell increased slightly or remained constant (Fig. 1) .
During the next week, the percentage of cells infected in the IFN-y-treated cultures continued to decrease and the average number of rickettsiae per infected cell did not increase. After derived from nine independent rickettsial infections as follows: two cultures each were derived from seven independent infections and a single culture was derived from each of the remaining two infections. In one of the infections with two cultures, there was one culture from which the rickettsiae were eliminated and one culture in which the rickettsiae persisted. In the other six infections with two cultures, the rickettsiae either were eliminated or persisted in both cultures. The infecting rickettsiae used in these experiments were all from the same seed pool.
In one experiment, two infected. IFN-y-treated cultures that became persistently infected with rickettsiae were monitored for over 8 weeks (Fig. 2) . The percentage of cells infected and the average number of rickettsiae per infected cell in these cultures increased between days 14 and 24.
Then these parameters, particularly the average number of rickettsiae per infected cell, fluctuated in a cyclic manner (Fig. 2) .
To calculate the growth rates of rickettsiae in cultures of growing L929 cells, consideration must be given to the number of L929 cells per culture as well as the parameters of rickettsial infection discussed above. In the 10 cultures in which L929 cell growth was monitored, the rickettsiae in the attached cells in the untreated cultures doubled 2.0 ± 0.2 times per day from days 0 to 3, and the rickettsiae in the attached cells in the IFN-y-treated cultures doubled 0.3 ± 0.5 times per day during this time interval. From days 3 to 7, the number of doublings of rickettsiae per day in the IFNy-treated cultures was -0.4 ± 0.5, indicating that the numbers of rickettsiae in the attached cells decreased during this time interval. However, in the IFN-y-treated cultures in which the rickettsliie Established persistent infections, the rickettsiae doubled 2.2 ± 0.6 times per day between days 14 and 17, indicating that their growth returned to the control rate and was no longer being inhibited by IFN-,y. When very small percentages of cells were infected (as in the infected, IFN-y-treated cultures from which the rickettsiae were eliminated), the calculated numbers of rickettsial doublings at later times would have had a large error due to the small numbers of cells examined for rickettsiae. Therefore, these values are not given.
(ii) Growth and viability of L929 cells. Growth and viability of the L929 cells were examined to determine whether early differences in these parameters might be related to the outcome of the rickettsial infection in the IFN--y-treated cultures. Between 0 and 3 days after infection, the growth of the infected, IFN--y-treated L929 cell cultures was suppressed relative to all other cultures (mock-infected, untreated cultures; mock-infected, IFN--y-treated cultures; and infected, untreated cultures) (P < 0.001 [ Fig. 3]) . Furthermore, on day 3, in these infected, IFN-y-treated cultures, substantial percentages of the cells were dead, whereas very few cells were dead in the other cultures. Thus, the rickettsial infection and the treatment with IFN-y were harmful for the L929 cells. This early suppression of L929 cell growth and killing of some of the L929 cells occurred in the IFN-y-treated cultures from which the rickettsiae were eliminated, as well as the IFN-y-treated cultures that eventually became persistently infected. It was not possible to predict the outcome of a particular infection from the early growth pattern of the culture.
Suppression of cell growth in the mock-infected, IFNy-treated cultures was less precipitous and was first detected between days 3 and 7. After day 7, the growth of the mock-infected, IFN-y-treated cultures was similar to the growth of the infected, IFN-y-treated cultures from which the rickettsiae were eliminated (Fig. 3) . Between days 17 and 28, the growth of the IFN-y-treated, persistently infected cultures was suppressed relative to the growth of the IFN--y-treated cultures from which the rickettsiae were eliminated (Fig. 3) . This suppression of cell growth may be related to the rickettsial burden in these persistently infected cells.
Detachment of cells in the various cultures was also evaluated to determine whether there were any differences between the IFN-y-treated cultures from which the rickettsiae were eliminated and the IFN--y-treated cultures that became persistently infected. Significantly, during the entire 28-day period, cell detachment was similar in the cultures from which the rickettsiae were eliminated and the cultures that became persistently infected. The percentages (mean + standard deviation) of cells that were detached on days 3, 7, 10, 14, 17, 21, 24, and 28 were, respectively, 11 + 5, 8 ± 6, 6 + 2, 5 + 1, 3 ± 1, 2 ± 0, 3 ± 1, and 2 ± 0 in the cultures from which the rickettsiae were eliminated and 10 ± 2, 9 ± 3, 8 ± 7, 5 ± 3, 4 ± 2, 3 ± 1, 4 ± 3, and 2 ± 1 in the cultures that became persistently infected. Less than 5% of the cells were detached in the mock-infected cultures at each time of cell harvest. In the infected, untreated cultures, less than 5% of the cells were detached on day 3, but as the infection progressed more cells usually became detached (data not shown).
(iii) Assay of IFN--y-treated L929 cells for viable rickettsiae.
Four IFN--y-treated cultures that exhibited the elimination pattern and appeared to be free of rickettsiae were further evaluated by subculturing them for 2 weeks in the absence of IFN--y and staining them for rickettsiae. Subculture of the treated cells in medium without IFN--y was initiated on day 38 for two cultures derived from one infection and on day 42 for two cultures derived from another infection. Rickettsiae were not detected in these subcultures in any case.
Two IFN--y-treated cultures that were derived from a third infection and that exhibited rickettsial elimination were assayed for viable rickettsiae after treatment with IFN--y for 7, 14, 21, 28, or 35 days. Inoculation of the L929 cells into embryonated hen eggs was the method used for detection of viable rickettsiae in the cultures because it allowed the assay of large numbers of L929 cells. As anticipated on the basis of stains of the L929 cell cultures, after egg passage 1, all yolk sac smears prepared from eggs inoculated with infected L929 cells that had been treated with IFN-y for 7 days contained rickettsiae. In contrast, smears prepared from eggs inoculated with approximately 3.5 x 10" IFN-y-treated L929 cells from day 14, 21, 28, or 35 were negative for rickettsiae after egg passage 1. After egg passage 2, rickettsiae were detected in the L929 cell cultures at day 14 (five of six eggs) and day 21 (two of four eggs) but were not detected in the L929 cell cultures at day 28 and day 35. Assuming that inoculation of 42 rickettsiae per egg would have been detected in egg passage 1, one can conservatively estimate from these data that there was less than one viable rickettsia per 8,000 L929 cells on day 14 and thereafter. Because the L929 cells at day 28 and day 35 were negative for rickettsiae even after egg passage 2, there was much less than one rickettsia per 8,000 cells at those times. These data provide additional evidence for the elimination of the rickettsiae from the IFN-y-treated cultures that appeared to be free of rickettsiae as judged by staining.
Responsiveness of antibiotic-cured L929 cells derived from persistently infected, IFN--y-treated cultures to IFN--y. To determine whether the L929 cells in the persistently infected, IFN-y-treated cultures had lost the ability to respond to IFN--y, two cultures derived from different infections (experiments 427 and 87) were cured of their rickettsial infection and the ability of these cells to mount both IFN--y-induced antiviral and antirickettsial responses was evaluated. The rickettsiae were eliminated from the cells by treatment with erythromycin (experiment 427) or chloramphenicol (experiment 87) for 3 weeks with or without IFN-y.
Concentrations of IFN--y that protected normal L929 cells from the cytopathic effects of vesicular stomatis virus also protected the antibiotic-cured cells derived from the persistently infected, IFN-y-treated cultures (data not shown). IFN--y (12 U/ml) also inhibited the growth of R. prosazekii Madrid E in these cured cells ( Table 1 ). Cells that had been cultured without IFN-y during the antibiotic treatment and before the experiments supported rickettsial growth, except when IFN--y was present during the experiments (Table 1) . However, even when IFN--y was not added during the experiments, the rickettsiae did not grow (or grew very poorly) in cells that had been continuously maintained in the presence of IFN-y during the antibiotic treatment and before the experiments. These data indicate that the persistently infected, IFN-y-treated L929 cells, whether they were cured of their rickettsial infection with or without IFN-y, retained the ability to inhibit rickettsial growth when they were treated with IFN--y. The failure of R. prowazekii Madrid E to grow in the cells that had been cured in the presence of IFN--y, even when IFN--y was not added after infection, probably reflects the antirickettsial effects of the IFN-y that was present in these cultures before infection. Residual effects of the antibiotics used to cure the cells were not responsible for the lack of rickettsial growth in these cells because the cells supported rickettsial growth when they were infected with the IFN-y-resistant rickettsiae described below (data not shown). The parameters of rickettsial infection in antibiotic-cured cells that were infected with R.
prowazekii Madrid E and subcultured in the presence of IFN-y for 10 days exhibited patterns similar to those observed in standard L929 cells that were infected and treated with IFN-y (Fig. 4) . (Table 2) . However, although the growth rates of the four rickettsial isolates and R. prowazekii Madrid E were similar in untreated L929 cells, the growth rates of the four rickettsial isolates in IFN-'y-treated L929 cells were significantly higher than the growth rate of R. prow}'azekii Madrid E in IFN-y-treated L929 cells (Table 2) . A higher concentration of IFN-y (100 U/ml) did not cause a further reduction in the growth rates of the Madrid E strain or the rickettsiae isolated from persistently infected, IFN-y-treated L929 cells (data not shown). These data indicate that the rickettsiae isolated from persistently infected, IFN-y-treated L929 cells were less sensitive to the antirickettsial effect of IFN-y than R.
prowazekii Madrid E; however, these rickettsiae were not completely resistant to IFN-y. infected, IFN-y-treated L929 cells (data not shown) and were retained after the rickettsiae were grown in embryonated hen eggs (R. prowt'azekii 427 and R. prowazekii 87 [ (26) found that supernatant fluids collected from stimulated cultures of human leukocytes had a cytolytic effect on R. prowazekii-infected human fibroblasts and suggested that IFN-y was responsible for the cytolytic effect of the supernatant fluids. The present study indicates that IFN-y, in the absence of other lymphokines, has a toxic effect on R. prowazekii-infected mouse L929 cells. Macrophagelike RAW264.7 cells are also killed by the combination of IFN--y treatment and infection with R. prowazekii (16) (3, 10) . Furthermore, the virulence of the Madrid E strain has been reported to increase (9) or decrease (2) after passage in cell cultures. In addition, several drug-resistant or antibiotic-resistant substrains of R. prowazekii Madrid E have been isolated after laboratory passage of rickettsiae in the presence of paminobenzoic acid, 2,3-dimethyl quinoxaline-1,4-dioxide, acetylsalicylic acid, chloramphenicol, or erythromycin (20) (21) (22) (23) (24) . Mutants resistant to erythromycin or rifampin have also been selected after exposure of R. prowazekii Madrid E to N-methyl-N'-nitro-N-nitrosoguanidine (1). The molecular basis of these variations in the Madrid E strain has not been determined.
Because the Madrid E strain of R. prowi'azekii used in the present study had not been plaque purified, variant rickettsiae present at the time of infection may have been selected by subculturing the infected cells in the presence of IFN-y. Alternatively, the occurrence of a mutation sometime after infection may have been followed by selection of the altered rickettsiae. Regardless of the time at which mutation of the rickettsiae occurred, characterization of these altered rickettsiae should facilitate determination of the mechanisms by which IFN-y inhibits rickettsial growth in cultured cells.
